Our study successfully confirmed that aberrant FOXO3 upregulation is linked to worse HCC phenotypes, being responsible for the induction of a pro-survival autophagy that contributes to sorafenib resistance acquisition in HCC. This evidence concerns the gene FOXO3 and hepatocellular carcinoma.